Recombinomics | Elegant Evolution

Home Founder What's New In The News Consulting

H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies


Audio:Feb17 Mar17 Apr21 Apr26 RSS Feed twitter News Now                         


Brazil President In Hospital With Pneumonia / Flu-like Symptoms

Recombinomics Commentary 15:10
May 2, 2011

Brazilian President Dilma Rousseff is in hospital suffering from pneumonia, her spokesman Rodrigo Baena says.

Ms Rousseff had been admitted to a hospital in Sao Paulo on Saturday after suffering from severe flu symptoms for several days, he said.

He added that the president would stay a second night for further tests.

Ms Rousseff, 63, had to cancel her participation at the World Economic Forum in Rio de Janeiro on Friday because she felt ill.

The above report describes the likely infection of the President of Brazil with H1N1.  It also highlights the limitation of vaccination campaigns when H1N1 is circulating.  The President was vaccinated on April 25, 2011. 

However, the transcript of the 2011/2012 vaccine selection meeting in the United States details H1N1 infections in vaccinated US military, as reported by the Air Force.  Release of sequences from US vaccinated cases identified the Chihuahua sub-clade, adding additional support for vaccine escape by the sub-clade reported in Mexico in public reports, and in South America in anecdotal reports which icluded additional examples with D225N in severe or fatal cases, leading to WHO announced pandemic alert.

Moreover, President Rousseff was diagnosed in early 2011 with H1N1, providing further support for evolution away from prior H1N1 sub-clade, as well as the current vaccine used on April 25, 2011.

The above cases follow similar reports for the President of Venezuela, Hugo Chavez, who was also forced to cancel a public address due to “heavy flu” last month.

The above reports support the transmission of H1N1 at the highest levels in South American governments and raise serious concerns about the efficacy of aggressive 2011 H1N1 vaccine campaigns with a vaccine target from early 2009.

Media link

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings

Home | Founder | What's New | In The News | Contact Us

© 2011 Recombinomics.  All rights reserved.